3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Other neoplasm
1
Conditions
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Interventions
Colposcopy
5
Biopsy
3
Vaginal Smears
2
Polymerase Chain Reaction
2
Imiquimod
2
human papillomavirus vaccine, TA
1
human papillomavirus vaccine, L1 type 16, 18
1
Zoledronic Acid
1
Watchful Waiting
1
Tretinoin
1
Transurethral Resection of Prostate
1
Spectrum Analysis
1
Spectrometry, Fluorescence
1
Sodium Chloride
1
Pregnancy Tests
1
Papanicolaou Test
1
Microarray Analysis
1
Immunohistochemistry
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Human Papillomavirus DNA Tests
1
Histological Techniques
1
Folic Acid
1
Fluorophotometry
1
Flow Cytometry
1
Fenretinide
1
Eflornithine
1
Conization
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Dysplasia
×
Transurethral Resection of Prostate
×
Other neoplasm
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled